These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9686407)

  • 21. Cocaine-induced alterations in the density of monoaminergic receptors in the embryonic guinea pig cerebral wall.
    Lidow MS; Trakht T; Howard RL
    Synapse; 1999 Jun; 32(3):225-37. PubMed ID: 10340632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group.
    Traynor JR; Guo L; Coop A; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1093-9. PubMed ID: 10565829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotransmitter and neuroendocrine abnormalities associated with cocaine use.
    Dackis C; Gold MS
    Psychiatr Med; 1985; 3(4):461-83. PubMed ID: 2829287
    [No Abstract]   [Full Text] [Related]  

  • 24. Substance use of disorders in HIV-infected patients: impact and new treatment strategies.
    Fiellin DA
    Top HIV Med; 2004; 12(3):77-82. PubMed ID: 15310938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of new compounds for opioid activity.
    Woods J; Medzihradsky F; Smith C; Winger G; France C
    NIDA Res Monogr; 1988; 90():421-67. PubMed ID: 2855859
    [No Abstract]   [Full Text] [Related]  

  • 26. Opiate receptors and their implications for drug addiction.
    Simon EJ
    NIDA Res Monogr; 1980 Mar; 30():303-8. PubMed ID: 6256635
    [No Abstract]   [Full Text] [Related]  

  • 27. Highly selective fluorescent analogue of the potent delta-opioid receptor antagonist Dmt-Tic.
    Balboni G; Salvadori S; Dal Piaz A; Bortolotti F; Argazzi R; Negri L; Lattanzi R; Bryant SD; Jinsmaa Y; Lazarus LH
    J Med Chem; 2004 Dec; 47(26):6541-6. PubMed ID: 15588089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testing medications for the treatment of addiction in pregnancy: one reviewer's opinion.
    Wright C
    NIDA Res Monogr; 1995; 149():231-5. PubMed ID: 8775843
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.
    Kreek MJ; Bart G; Lilly C; LaForge KS; Nielsen DA
    Pharmacol Rev; 2005 Mar; 57(1):1-26. PubMed ID: 15734726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of toxic effects of cocaine on dopamine or serotonin neurons in the rat brain.
    Seiden LS; Kleven MS
    NIDA Res Monogr; 1988; 88():276-89. PubMed ID: 3145452
    [No Abstract]   [Full Text] [Related]  

  • 31. Proterguride, a highly potent dopamine receptor agonist promising for transdermal administration in Parkinson's disease: interactions with alpha(1)-, 5-HT(2)- and H(1)-receptors.
    Schurad B; Horowski R; Jähnichen S; Görnemann T; Tack J; Pertz HH
    Life Sci; 2006 Apr; 78(20):2358-64. PubMed ID: 16310806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopaminergic and serotonergic autoreceptor stimulation effects are equivalent and additive in the suppression of spontaneous and cocaine induced locomotor activity.
    Carey RJ; DePalma G; Damianopoulos E; Hopkins A; Shanahan A; Müller CP; Huston JP
    Brain Res; 2004 Sep; 1019(1-2):134-43. PubMed ID: 15306247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism of 5-hydroxytryptamine(4) receptors attenuates hyperactivity induced by cocaine: putative role for 5-hydroxytryptamine(4) receptors in the nucleus accumbens shell.
    McMahon LR; Cunningham KA
    J Pharmacol Exp Ther; 1999 Oct; 291(1):300-7. PubMed ID: 10490917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon.
    Irving HR; Tan YY; Tochon-Danguy N; Liu H; Chetty N; Desmond PV; Pouton CW; Coupar IM
    Life Sci; 2007 Mar; 80(13):1198-205. PubMed ID: 17258778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic pentapeptides of chiral sequence DLDDL as scaffold for antagonism of G-protein coupled receptors: synthesis, activity and conformational analysis by NMR and molecular dynamics of ITF 1565 a substance P inhibitor.
    Porcelli M; Casu M; Lai A; Saba G; Pinori M; Cappelletti S; Mascagni P
    Biopolymers; 1999 Aug; 50(2):211-9. PubMed ID: 10380345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
    J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
    Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of dopamine system in regulation of Na+,K+-ATPase in the striatum upon activation of opioid receptors by morphine.
    Wu ZQ; Chen J; Chi ZQ; Liu JG
    Mol Pharmacol; 2007 Feb; 71(2):519-30. PubMed ID: 17068092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medications development: successes and challenges.
    Vocci F; Ling W
    Pharmacol Ther; 2005 Oct; 108(1):94-108. PubMed ID: 16083966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview of potential treatment medications for cocaine dependence.
    McCance EF
    NIDA Res Monogr; 1997; 175():36-72. PubMed ID: 9467792
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.